Assessing Cognitive Function in Patients with Schizophrenia
A panel of medical experts discuss the clinical and financial considerations surrounding the treatment of patients diagnosed with schizophrenia.
Social Determinants of Health Limiting Optimal Treatment for Schizophrenia
Social determinants of health impacting the treatment landscape for schizophrenia are discussed.
Patient and Provider Education on Biosimilars
A panel of experts reviews the emerging interchangeable biosimilars and best practices on how to educate providers and patients on these treatment options.
Interchangeability In Biosimilars
Maia Kayal, MD, MS, and Jonathan Kay, MD, define interchangeability and review the details of a switching study.
Examining Cognitive Impairment Associated with Schizophrenia
Carlos Larrauri, APRN, details the signs and symptoms necessary to make a schizophrenia diagnosis.
Schizophrenia Disease State Overview
John J. Miller, MD, and Nev Jones, PhD, open a discussion providing an overview on the current state of patients with schizophrenia.
Patient-Centered Focus Driving
With their final thoughts, the panelists emphasize patient-centered care is at the forefront of critical MS treatment considerations for providers.
Overall Treatment Objectives for Patients with MS
A comprehensive look into MS treatment objectives is provided.
Key Takeaways Surrounding the Treatment of HIV
Panelists provide their closing thoughts on optimizing the management of HIV.
Trajectory of the HIV Treatment Landscape
The panel of experts discusses emerging and anticipated changes to the HIV treatment landscape.
Updates in MS Clinical Trials
A discussion surrounding clinical trials in multiple sclerosis is led by Dr Haumschild.
Utilizing BTK Inhibitors to Address Unmet Needs in MS
The panel expands on the role of BTK inhibitors in the MS treatment landscape.
Unmet Needs in the Treatment of HIV
The panel discusses unmet needs that remain in the treatment and management of HIV.
Collaborative Care Driving Optimal Care for Patients Diagnosed with HIV
Dr Welch leads a discussion on collaborations between payers, patients, and providers to optimize the care of patients with HIV.
Key Takeaways for Immunizing against RSV
In their closing thoughts, the panelists provide their key takeaways regarding immunizing against RSV.
Bruton Kinase Inhibitors (BTKi) Use in MS Treatment
BTK inhibitor implementation for MS treatment is explored.
Switching Agents Due to Underwhelming MS Treatment Response Rates
The panelists provide insights into the decision-making process behind switching MS treatment strategies due to lacking or failed therapies.
Real-World Evidence in HIV
Key opinion leaders discuss the value of real-world evidence in the management of HIV.
Evaluating Effectiveness of A Patient's Current HIV Treatment Regimen
Assessing the quality of an HIV treatment plan is crucial to patient prognosis.
Unmet Needs Surrounding RSV Treatments
In her closing thoughts, Dr Filer provides insights into the unmet needs in the treatment of RSV.
Promoting Awareness for RSV Vaccines: Part 2
Discussion surrounding promotion of RSV vaccine awareness is further discussed.
Promoting Awareness for RSV Vaccines: Part 1
The panel offers strategies for being proactive .
Mitigating Clinical Inertia in MS Treatment Through Payer-Provider Collaboration
Dr Haumschild leads a discussion surrounding patient and provider collaboration to avoid clinical inertia in MS treatment pathways.
Early Treatment and Frontline Therapies for Patients with MS
Frontline treatment options and the benefits of early intervention of MS are illustrated.
Navigating HIV Treatment Barriers Associated with Pill Burden
Medical experts discuss the significance of pill burden in the HIV treatment pathway.
Long-Acting Injectables in the HIV Treatment Landscape
The role of and indication for long-acting injectables is highlighted as a treatment approach for HIV.
Payer Considerations for RSV Vaccine Coverage
Experts discuss the financial needs for RSV vaccines through a payer lens.
Navigating the RSV Treatment Landscape and Associated Financial Considerations
Financial burden associated with RSV treatment is explored by a medical expert.
Addressing Barriers Surrounding RSV Vaccines
Experts highlight the potential obstacles for RSV vaccines.
Current MS Treatment Paradigms
Key opinion leaders highlight the MS treatment landscape.
